Login / Signup

Preclinical pharmacokinetics and tolerability of a novel meglumine-based parenteral solution of topiramate and topiramate combinations for treatment of status epilepticus.

Chris RundfeldtPavel KleinDetlev BoisonAlexander RotenbergRaimondo D'AmbrosioCliff EastmanBenton PurnellMadhuvika MuruganHoward P GoodkinWolfgang Löscher
Published in: Epilepsia (2023)
In conclusion, the novel meglumine-based solution of TPM presented here may be well suited for clinical development.
Keyphrases
  • open label
  • cell therapy
  • randomized controlled trial
  • double blind